Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Integrated Genomics of Ovarian Xenograft Tumor Progression and Chemotherapy Response
PubMed Full text in PMC Similar studies Analyze with GEO2R
Xenograft ovarian tumor response to anti-cancer therapeutic MT19: time course
PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet
Genome-wide methylation and expression profiling study identifies candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer.
PubMed Similar studies Analyze with GEO2R
Genome-wide Methylation Profiling Identifies Candidate DNA Methylation Drivers of Acquired Cisplatin Resistance in Ovarian Cancer.
Gene expression profiling in A2780, CP70 and CP70 following Decitabine and/or PXD101 treatment
Genome-wide methylation profiling of ovarian cancer patient-derived xenograft (PDXs) treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways
Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Identification of a Potential Ovarian Cancer Stem Cell Gene Expression Profile from Advanced Stage Papillary Serous Ovarian Cancer
Transcriptome Profiling and Characterization of Peritoneal Metastasis Ovarian Cancer Xenografts in Humanized Mice
Expression data from exponentially proliferating ovarian cancer cell lines
Chemotherapy induced dynamic gene expression changes in vivo are prognostic in ovarian cancer
Tissue Specific Pathways for Estrogen Regulation of Ovarian Cancer Growth and Metastasis
Ovarian cancer intraperitoneal xenograft model
Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers
Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer
Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
Evaluating cross-hybridization of murine cDNA to the Affymetrix Human Genome U133 Plus 2.0 chipset
Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI)
Exression profiling of 9-cisRA in adrenocortical carcinoma cell line
Non-steroidal Anti-inflammatory Drugs Decrease E2F1 Expression and Inhibit Cell Growth in Ovarian Cancer Cells
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on